Gene Expression Profile Analysis According to Recurrent Gene Copy Number Abnormalities Defines a Diffuse Large B-Cell Lymphoma Subgroup Characterized by 9p21 Locus Deletion, Ribosome Machinery Deregulation and Poor Prognosis. A GELA Study

被引：0

作者：

Jardin, Fabrice ^{[1
]}

Jais, Jean-Philippe ^{[2
]}

Molina, Thierry Jo ^{[3
]}

Parmentier, Francoise ^{[1
]}

Picquenot, Jean-Michel ^{[1
]}

Ruminy, Philippe ^{[1
]}

Tilly, Herve ^{[4
]}

Bastard, Christian ^{[1
]}

Salles, Gilles Andre ^{[5
]}

Coiffier, Bertrand ^{[5
]}

Haioun, Corinne ^{[6
]}

Leroy, Karen ^{[7
]}

机构：

[1] Ctr Henri Becquerel, INSERM, U918, F-76038 Rouen, France

[2] Univ Paris 05, Hop Necker, EA 4067, Paris, France

[3] Univ Paris Descarte, Hotel Dieu Hosp, Paris, France

[4] Ctr Henri Becquerel, F-76038 Rouen, France

[5] Ctr Hosp Lyon Sud, F-69310 Pierre Benite, France

[6] Hop Henri Mondor, Serv Hematol Clin, F-94010 Creteil, France

[7] Henri Mondor Hosp, INSERM, U841, Creteil, France

来源：

BLOOD | 2008年 / 112卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：298 / 299

页数：2

共 3 条

[1] Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study
Jardin, Fabrice
Jais, Jean-Philippe
Molina, Thierry-Jo
Parmentier, Francoise
Picquenot, Jean-Michel
Ruminy, Philippe
Tilly, Herve
Bastard, Christian
Salles, Gilles-Andre
Feugier, Pierre
Thieblemont, Catherine
Gisselbrecht, Christian
de Reynies, Aurelien
Coiffier, Bertrand
Haioun, Corinne
Leroy, Karen
BLOOD, 2010, 116 (07) : 1092 - 1104
[2] CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
Hu, Shimin
Xu-Monette, Zijun Y.
Balasubramanyam, Aarthi
Manyam, Ganiraju C.
Visco, Carlo
Tzankov, Alexander
Liu, Wei-min
Miranda, Roberto N.
Zhang, Li
Montes-Moreno, Santiago
Dybkaer, Karen
Chiu, April
Orazi, Attilio
Zu, Youli
Bhagat, Govind
Richards, Kristy L.
Hsi, Eric D.
Choi, William W. L.
van Krieken, J. Han
Huang, Qin
Huh, Jooryung
Ai, Weiyun
Ponzoni, Maurilio
Ferreri, Andres J. M.
Zhao, Xiaoying
Winter, Jane N.
Zhang, Mingzhi
Li, Ling
Moller, Michael B.
Piris, Miguel A.
Li, Yong
Go, Ronald S.
Wu, Lin
Medeiros, L. Jeffrey
Young, Ken H.
BLOOD, 2013, 121 (14) : 2715 - 2724
[3] Integrated Analysis of High-Resolution Gene Expression and Copy Number Profiling Identified Biallelic Deletion of CDKN2A/2B Tumor Suppressor Locus As the Most Frequent and Unique Genomic Abnormality in Diffuse Large B-Cell Lymphoma (DLBCL) with Strong Prognostic Value in Both GCB and ABC Subtypes and Not Overcome by a Dose-Intensive Immunochemotherapy Regimen Plus Rituximab. Results of a Prospective GELA Clinical Trial Program
Jardin, Fabrice
Mareschal, Sylvain
Figeac, Martin
Jais, Jean-Philippe
Leroy, Karen
Copie-Bergman, Christiane
Salles, Gilles Andre
Coiffier, Bertrand
Delarue, Richard
Peyrade, Frederic
Bosly, Andre
Ketterer, Nicolas
Haioun, Corinne
Tilly, Herve
Molina, Thierry Jo
BLOOD, 2012, 120 (21)

← 1 →